RBC cuts Biogen price target to $256
RBC Capital lowered its Biogen price target to $256.00 per share from $260.00, according to Benzinga’s ratings-action report.
Story updates
02:19:31 PM UTC
SquawkNews
Biogen Is Maintained at Outperform by RBC Capital